Summary & Overview
CPT 92520: Laryngeal Function Studies (Aerodynamic and Acoustic Testing)
CPT code 92520 represents laryngeal function studies, specifically aerodynamic and acoustic testing, which are critical for diagnosing and managing voice and laryngeal disorders. This code is widely used by speech-language pathologists and otolaryngologists in hospital outpatient settings to assess patients with conditions such as dysphonia, vocal cord paralysis, and other voice disturbances. Nationally, the code is recognized by major payers including Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare, ensuring broad coverage for these essential diagnostic services.
This publication provides a comprehensive overview of CPT 92520, including payer coverage, clinical context, and related billing codes. Readers will gain insights into the typical clinical indications, associated diagnoses, and the role of laryngeal function studies in patient care. The report also highlights relevant policy updates and benchmarks, offering a clear understanding of how this code fits within the broader landscape of speech-language pathology and otolaryngology services. Key modifiers and related CPT codes are discussed to support accurate billing and coding practices.
CPT Code Overview
CPT 92520 is used to report laryngeal function studies, which include aerodynamic testing and acoustic testing. These procedures are essential for evaluating the function of the larynx, particularly in patients with voice disorders or suspected laryngeal pathology. The service is typically performed by specialists in speech-language pathology or otolaryngology. The most common site of service for these studies is the hospital outpatient department, where both therapy and non-therapy services may be provided as appropriate.
Clinical & Coding Specifications
Clinical Context
A patient presents to a hospital outpatient department with persistent hoarseness and difficulty speaking. The otolaryngologist suspects a disorder affecting the vocal cords or larynx, such as dysphonia or vocal cord paralysis. To assess the patient's laryngeal function, the provider performs laryngeal function studies, including aerodynamic and acoustic testing. These tests help evaluate airflow, pressure, and sound characteristics during phonation, guiding diagnosis and treatment planning. The clinical workflow typically involves referral from a primary care provider or speech-language pathologist, followed by specialized testing and interpretation by an otolaryngologist or audiologist.
Coding Specifications
-
Modifiers:
- Modifier
26: Used to indicate the professional component of the service, such as interpretation and reporting of the laryngeal function studies. - Modifier
TC: Used to indicate the technical component, which covers the equipment and technical staff involved in performing the tests.
- Modifier
-
Provider Taxonomies:
| Taxonomy Code | Specialty |
|---|---|
207Y00000X | Otolaryngologist |
231H00000X | Audiologist |
207K00000X | Allergy & Immunology Physician |
These specialties are typically involved in the assessment and management of laryngeal function disorders.
Related Diagnoses
-
R49.0- Dysphonia- Indicates abnormal voice quality, such as hoarseness, which is a primary reason for laryngeal function studies.
-
J38.00- Paralysis of vocal cords and larynx, unspecified- Used when vocal cord or laryngeal paralysis is suspected, requiring functional assessment.
-
J38.2- Nodules of vocal cords- Vocal cord nodules can cause voice disturbances; laryngeal function studies help evaluate their impact.
-
J38.3- Other diseases of vocal cords- Covers other vocal cord pathologies that may affect laryngeal function and require testing.
-
R49.9- Unspecified voice disturbance- Used when the exact cause of voice disturbance is unclear; laryngeal function studies assist in diagnosis.
Related CPT Codes
-
92521- Evaluation of speech fluency (eg, stuttering, cluttering)- Used to assess fluency disorders; may be performed alongside laryngeal function studies if speech fluency is affected.
-
92522- Evaluation of speech sound production (eg, articulation, phonological process, apraxia, dysarthria)- Addresses articulation and speech sound disorders; relevant when laryngeal dysfunction impacts speech production.
-
92523- With evaluation of language comprehension and expression (eg, receptive and expressive language)- Used when both speech and language abilities are evaluated; may be combined with laryngeal function studies for comprehensive assessment.
-
92524- Behavioral and qualitative analysis of voice and resonance- Focuses on voice and resonance characteristics; often used together with laryngeal function studies to assess voice disorders.
-
92526- Oral function therapy- Therapy for oral function; may follow diagnostic laryngeal function studies if treatment is indicated.
These codes are commonly used in conjunction with or as alternatives to 92520 depending on the patient's clinical presentation and assessment needs.
National Reimbursement Benchmarks
Medicare's national mean rate for CPT code 92520 is $94.66, which is higher than Aetna ($62.11) and Blue Cross Blue Shield ($80.13), but lower than Cigna ($99.83), UnitedHealth Group ($108.95), and the BUCA average ($83.78). The BUCA mean rate, representing the average of major commercial payers, stands at $83.78, indicating that Medicare is generally competitive with commercial rates, though UnitedHealth Group and Cigna both exceed Medicare's mean.
Rate dispersion varies significantly across payers. Aetna has the tightest range between the 25th and 75th percentiles ($21.34), suggesting less variability in reimbursement. UnitedHealth Group shows the widest spread ($60.93), indicating greater variability in rates paid. Medicare's range is also relatively narrow ($11.00), reflecting consistent payment levels. The table and chart below present the full breakdown of national benchmarks for each payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.